Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • AC Immune News

    2,35 € -0,84% -0,02 €
    08:04:05 Uhr München aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A2AR5F
    ISIN: CH0329023102
    US-Symbol: ACIU
    Typ: Aktie

    AC Immune News

    14.03.24 - 4investors
    AC Immune verringert Verlust - wichtige Daten in der zweiten Jahreshälfte 2024
    14.03.24 - GlobeNewswire
    AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
    AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update ACI-24.060 ABATE Phase 2 trial to report Abeta-PET imaging results in Q2 and H2 ACI-...
    22.02.24 - GlobeNewswire
    AC Immune Announces Upcoming Presentations at AD/PD™ 2024
    AC Immune Announces Upcoming Presentations at AD/PD™ 2024 Multiple presentations at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2024) ...
    22.01.24 - 4investors
    AC Immune erhält Rechte an Antikörpern von Genentech zurück
    22.01.24 - GlobeNewswire
    AC Immune to Regain Global Rights to Crenezumab and Semorinemab
    AC Immune to Regain Global Rights to Crenezumab and Semorinemab
    03.01.24 - GlobeNewswire
    AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases
    AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases
    28.12.23 - PR Newswire
    Thinking about buying stock in Riot Platforms, Coherus Biosciences, AC Immune, Wisekey International Holding, or NXU Inc.?
    Thinking about buying stock in Riot Platforms, Coherus Biosciences, AC Immune, Wisekey International Holding, or NXU Inc.? PR Newswire
    15.12.23 - 4investors
    AC Immune: Interessante News im Doppelpack - Alzheimer-Studie und frisches Geld
    15.12.23 - GlobeNewswire
    AC Immune Announces Pricing of Underwritten Offering of Common Shares
    AC Immune Announces Pricing of Underwritten Offering of Common Shares Lausanne, Switzerland, December 15, 2023 – AC Immune SA (Nasdaq: ACIU) (the “Company” or “AC ...
    15.12.23 - GlobeNewswire
    AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial
    AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial Potentially registration-​enabling Phase 2b study (ReTain) will evaluate ...
    01.12.23 - GlobeNewswire
    AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
    AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
    07.11.23 - GlobeNewswire
    AC Immune to Present at the Jefferies 2023 London Healthcare Conference
    AC Immune to Present at the Jefferies 2023 London Healthcare Conference Lausanne, Switzerland, November 7, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-​stage ...
    03.11.23 - 4investors
    AC Immune: Meilensteine voraus - finanziert bis Ende 2024
    03.11.23 - GlobeNewswire
    AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
    AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update Results from amyloid plaque reduction analysis (Abeta-PET) after 6 months of ...
    02.11.23 - GlobeNewswire
    AC Immune to Host KOL Webinar on Amyloid Plaque PET Imaging in Alzheimer’s Disease as a Surrogate of Clinical Efficacy on November 9, 2023
    AC Immune to Host KOL Webinar on Amyloid Plaque PET Imaging in Alzheimer’s Disease as a Surrogate of Clinical Efficacy on November 9, 2023 Lausanne, Switzerland, ...
    27.10.23 - GlobeNewswire
    AC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic
    PRESS RELEASE
    17.10.23 - GlobeNewswire
    AC Immune Announces Upcoming Presentations at the 16th CTAD Conference
    AC Immune Announces Upcoming Presentations at the 16 th CTAD Conference Lausanne, Switzerland, October 17, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-​stage ...
    05.10.23 - GlobeNewswire
    AC Immune to Present at the Jefferies 2023 CNS & Neuro Summit in October 2023
    AC Immune to Present at the Jefferies 2023 CNS & Neuro Summit in October 2023 Lausanne, Switzerland, October 5, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-​stage ...
    05.09.23 - GlobeNewswire
    AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023
    AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023 Lausanne, Switzerland, September 05 , 202 3 – AC Immune SA ...
    04.08.23 - 4investors
    AC Immune: Eine ganze Reihe von Entwicklungs-Meilensteinen steht an

    Newssuche

    Videos

    newspaper
    09:30 Uhr
    Technical Trading: Gold mit weiterem Potenzial
    Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »